Local GPCR density tips the balance of μ-opioid receptor trafficking

Michael D Holsey1,2,3, Alexey Bondar4,5, Peter Geggier2,6

  • 1Department of Physiology and Cellular Biophysics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Insights

Receptor density controls G protein-coupled receptor (GPCR) signaling and trafficking. Higher GPCR density promotes μ-opioid receptor (MOR) trafficking by enhancing interactions with GRK2/3 and β-arrestin, while class B GPCRs inhibit this process.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Pharmacology

Background:

  • The precise role of G protein-coupled receptor (GPCR) surface density in regulating downstream signaling and trafficking remains incompletely understood.
  • GPCRs are crucial cell surface receptors involved in numerous physiological processes, making their regulation a key area of research.

Purpose of the Study:

  • To investigate how local surface density of the μ-opioid receptor (MOR) influences its engagement with G protein signaling and β-arrestin-dependent trafficking pathways.
  • To elucidate the mechanisms by which different classes of GPCRs affect MOR trafficking.

Main Methods:

  • Single-particle tracking of the μ-opioid receptor (MOR) in live cells.
  • Manipulation of MOR surface density and co-expression of other GPCRs (class A and class B).
  • Assessment of G protein signaling and GRK2/3-β-arrestin-dependent trafficking.

Main Results:

  • MOR surface density differentially regulates G protein signaling and GRK2/3-β-arrestin-dependent trafficking.
  • At low MOR density, G protein activation occurs, but trafficking into clathrin-coated structures is impaired.
  • Increased MOR density, co-expression of class A GPCRs, or elevated GRK2/β-arrestin rescues MOR trafficking; class B GPCRs (V2R) inhibit MOR trafficking at all densities.

Conclusions:

  • GPCR density is a critical determinant of receptor signaling and trafficking dynamics.
  • A model is proposed where increased class A GPCR density facilitates productive GRK2/3 and β-arrestin interactions, promoting trafficking.
  • Class B GPCRs can sequester β-arrestin, thereby blocking the trafficking of other GPCRs like MOR.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...